• Investing Ideas
  • /
  • Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies
34 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

CALTX

Calliditas Therapeutics
kr101.00-12.6%-20.3%kr5.4bkr208.00PS4.5xE48.8%n/a

SPRINT

Sprint Bioscience
kr1.3219.6%91.9%kr92.2mkr3.20PS1.8xS34.0%n/a

NEWBRY

Newbury Pharmaceuticals
kr3.43-1.7%-40.9%kr83.2mkr8.00PS3.6xE112.9%n/a

ORX

Orexo
kr16.38-0.6%14.2%kr564.3mkr22.50PB9.6xE75.1%n/a

CLBIO

Corline Biomedical
kr11.55-6.9%15.5%kr248.2mkr32.00PS7xE71.1%n/a

MAGLE

Magle Chemoswed Holding
kr33.601.8%12.8%kr362.9mkr40.00PE29.8xE41.2%n/a

SENZA

SenzaGen
kr6.627.1%-33.1%kr160.1mkr17.75PS3.2xE84.0%n/a

XBRANE

Xbrane Biopharma
kr0.36-9.4%-99.6%kr547.6mn/aPS2.3xE126.0%n/a

SOBI

Swedish Orphan Biovitrum
kr254.20-4.6%-5.9%kr86.4bkr314.11PE35.9xE21.7%n/a

XSPRAY

Xspray Pharma
kr40.40-0.7%-40.6%kr1.3bkr107.00PB1.8xS86.7%n/a

CAMX

Camurus
kr488.20-2.9%116.6%kr28.1bkr577.17PE65.2xE50.0%n/a

EEVIA

Eevia Health Oyj
kr1.48-11.9%-10.3%kr52.9mn/aPB1.1xn/an/a

VITR

Vitrolife
kr191.002.6%-11.8%kr25.9bkr246.67PS7.4xE102.2%0.5%

SPAGO

Spago Nanomedical
kr0.3013.4%-61.5%kr68.3mn/aPS11.5xE56.0%n/a

DVYSR

Devyser Diagnostics
kr104.000%34.4%kr1.7bkr115.39PS10xE99.3%n/a

AROC

AroCell
kr0.350%-45.4%kr81.3mkr1.30PS1.9xE28.7%n/a

XBRANE BTU

Xbrane Biopharma
kr11.60-8.7%n/akr14.8mkr1,431.06PB0.09xE126.0%n/a

BIOA B

BioArctic
kr202.40-1.4%-15.5%kr17.9bkr366.20PE78xE48.2%0%

BIOG B

BioGaia
kr118.702.4%29.2%kr12.0bkr140.00PE32.8xE8.9%5.8%

SOBI BTA

Swedish Orphan Biovitrum
kr221.000.5%n/akr74.3bkr288.15PE23.8xE20.6%n/a

ONCO

Oncopeptides
kr5.236.3%-52.8%kr516.5mkr6.80PS14.7xE40.4%n/a

SECARE

Swedencare
kr61.45-7.2%135.0%kr9.8bkr68.00PE166.5xE50.4%0.4%

AZN

AstraZeneca
UK£1,502.504.5%-2.6%UK£170.9bUK£1,779.48PE35.7xE16.5%2.1%

MCAP

MedCap
kr411.000.6%51.7%kr6.1bn/aPE35.3xn/an/a
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.